Farrerol
(Synonyms: 杜鹃素) 目录号 : GC38222
Farrerol是一种从传统中药兴安杜鹃(Rhododendron dauricum L. Ericaceae)中分离出来的典型黄烷酮,对雌激素受体ERα和ERβ的IC50值分别为57μM和2.7μM。
Cas No.:24211-30-1
Sample solution is provided at 25 µL, 10mM.
Farrerol is a typical natural flavanone isolated from the traditional Chinese herb Rhododendron dauricum L.Ericaceae with IC50 values of 57μM and 2.7μM for estrogen receptors ERα and ERβ, respectively[1]. Farrerol, possessing anti-inflammatory, antioxidant, vasoactive, antitumor, and antimicrobial properties, is capable of preventing and treating diseases associated with oxidative stress, cancer, cardiovascular diseases, and bacterial infections[2][3][4][6].
In vitro, murine macrophage RAW 264.7 cells treated with different concentrations of Farrerol (0-20mg/L) for 18h or 24h induced the expression of antioxidant enzymes and increased the expression of HO-1 by activating Nrf2 and reducing the expression of Keap1[2]. Primary bovine mammary epithelial cells (bMEC) were incubated with Farrerol (4-16μg/ml) for 24h before infecting with S. aureus at a multiplicity of infection of 30 (MOI 30:1 bacteria per cell). All concentrations of Farrerol significantly inhibited S. aureus internalization into bMEC in a dose-dependent manner by downregulating the mRNA expression of tracheal antimicrobial peptide (TAP) and bovine neutrophil β-defensin 5 (BNBD5), and also suppressing S. aureus induced NF-kB activation in bMEC[3]. Farrerol (0, 40, 80, and 160μM) incubated human ovarian epithelial cancer SKOV3 cells for 24h or 48h decreased the viability of SKOV3 cells in a dose and time-dependent manner. Farrerol induced G2/M cell cycle arrest and apoptosis in cancer cells[4].
In vivo, hepatic injury mice models were administered Farrerol (40mg/kg) i.p. injections two times, 12h and 1h before the injection of Acetaminophen (APAP). Farrerol pretreatment alleviated acute liver failure and maintained the survival rate of mice by activation of both Nrf2-mediated antioxidative cascades and mitochondrial autophagy[5]. Farrerol (10mg/kg/day) injected intraperitoneally into Angiotensin II (Ang II)-treated mice model of myocardial remodeling for 2 days inhibited Ang II-induced cardiac hypertrophy and reduce heart weight/tibia ratio (HW/TL), inflammation, fibrosis, oxidative stress, the volume of cardiomyocytes and the proliferation and migration of fibroblast[6]. Mice received intraperitoneal injections of Farrerol (20mg/kg) daily for 8 consecutive days, starting 1 day before the unilateral ureteral obstruction (UUO) operation. Farrerol ameliorated renal injury and fibrosis in the UUO model by inhibiting oxidative stress, apoptosis, and inflammation[7].
References:
[1] Li Q Y, Chen L, Zhu YH, et al. Involvement of estrogen receptor-β in farrerol inhibition of rat thoracic aorta vascular smooth muscle cell proliferation. Acta Pharmacol Sin. 2011 Apr;32(4):433-40.
[2] Ci X X, Lv H M, Wang L D, et al. The antioxidative potential of Farrerolrrerol occurs via the activation of Nrf2 mediated HO-1 signaling in RAW 264.7 cells. Chem Biol Interact. 2015 Sep 5:239:192-9
[3] Yang Z T, Fu Y H, Liu B, et al. Farrerol regulates antimicrobial peptide expression and reduces Staphylococcus aureus internalization into bovine mammary epithelial cells.Microb Pathog. 2013 Dec:65:1-6.
[4] Chae J B, Kim J S, Choi S T, et al. Farrerol Induces Cancer Cell Death via ERK Activation in SKOV3 Cells and Attenuates TNF-α-Mediated Lipolysis. Int J Mol Sci. 2021 Aug 30;22(17):9400.
[5] Wang L D, Wei W, Xiao Q F, et al. Farrerol Ameliorates APAP-induced Hepatotoxicity via Activation of Nrf2 and Autophagy. Int J Biol Sci. 2019 Jan 29;15(4):788-799.
[6] He J, Xu D Y, Wang L, Yu X H. Farrerol prevents Angiotensin II-induced cardiac remodeling in vivo and in vitro. Front Pharmacol. 2023 Jan 4:13:1079251.
[7] Kim J Y, Leem J C, Park K K. Antioxidant, Anti-Apoptotic, and Anti-Inflammatory Effects of Farrerol in a Mouse Model of Obstructive Uropathy. Curr Issues Mol Biol. 2023 Jan 1;45(1):337-352.
Farrerol是一种从传统中药兴安杜鹃(Rhododendron dauricum L. Ericaceae)中分离出来的典型黄烷酮,对雌激素受体ERα和ERβ的IC50值分别为57μM和2.7μM[1]。Farrerol具有抗炎、抗氧化、血管活性、抗肿瘤和抗菌作用,可用于预防和治疗氧化应激相关疾病、治疗癌症、治疗心血管疾病以及预防和治疗细菌感染[2][3][4][6]。
体外实验中,用不同浓度的Farrerol(0-20mg/L)处理小鼠巨噬细胞RAW 264.7细胞18小时或24小时,可诱导抗氧化酶的表达,并通过激活Nrf2、降低Keap1的表达来增加HO-1的表达[2]。将原代牛乳腺上皮细胞(bMEC)用Farrerol(4-16μg/ml)预处理24小时后,再以感染复数为30(MOI 30:1细菌/细胞)感染金黄色葡萄球菌(S. aureus)。所有浓度的Farrerol均能以剂量依赖性方式显著抑制金黄色葡萄球菌侵入bMEC,通过下调气管抗菌肽(TAP)和牛中性粒细胞β防御素5(BNBD5)的mRNA表达,并抑制金黄色葡萄球菌诱导的bMEC中NF-kB的激活[3]。用Farrerol(0、40、80和160μM)处理人卵巢上皮癌SKOV3细胞24小时或48小时,可呈剂量和时间依赖性地降低SKOV3细胞的活性,并诱导癌细胞G2/M期细胞周期阻滞和细胞凋亡[4]。
体内实验中,肝损伤小鼠模型在注射对乙酰氨基酚(APAP)前12小时和1小时分别腹腔注射Farrerol(40mg/kg)两次,Farrerol预处理通过激活Nrf2介导的抗氧化级联反应和线粒体自噬,减轻急性肝衰竭并维持小鼠的存活率[5]。血管紧张素II(Ang II)处理的小鼠心肌重塑模型中,Farrerol(10mg/kg/day,i.p.,2天)抑制了Ang II诱导的心脏肥大,降低心重/胫骨长比(HW/TL),减轻炎症、纤维化、氧化应激,减少心肌细胞体积以及成纤维细胞的增殖和迁移[6]。小鼠在单侧输尿管梗阻(UUO)手术前1天开始,连续8天每日腹腔注射Farrerol(20mg/kg),Farrerol通过抑制氧化应激、凋亡和炎症,改善UUO模型中的肾脏损伤和纤维化[7]。
Cell experiment [1]: | |
Cell lines |
Human ovarian epithelial cancer SKOV3 cells |
Preparation Method |
SKOV3 cells were seeded (2×105 cells/mL) for 24h then treated with Farrerol (0, 40, 80, and 160μM) for 24 or 48h. After incubation, cell viability and cell cycle were analyzed. |
Reaction Conditions |
0, 40, 80, and 160μM; 24 or 48h |
Applications |
Farrerol reduced G0/G1-phase populations in SKOV3 cells and induced G2/M phase arrest, which suggested a possible mechanism by which the inhibitory effect of Farrerol on cancer cell growth occured. Farrerol caused DNA fragmentation and SKOV3 cell apoptosis by mediating ERK MAPK signaling. |
Animal experiment [2]: | |
Animal models |
Female B6 mice |
Preparation Method |
Mice were randomly divided into the following four groups : vehicle control group (0.5% DMSO), Farrerol only group (40mg/kg, dissolved in 0.5% DMSO), APAP only group (900mg/kg or 400mg/kg) and APAP (900mg/kg or 400mg/kg) + Farrerol (40mg/kg, dissolved in 0.5% DMSO) group. The mice were administered Farrerol (40mg/kg) i.p. injections two times, 12h and 1h before the injection of APAP (900mg/kg). The survival rates of the animals were monitored every 8h for 2 days. In addition, the mice were administered Farrerol (40mg/kg) i.p. injections two times, 12h and 1h before the injection of APAP (400mg/kg). After treatment with APAP (400mg/kg)for 6h, the mice were euthanized, their livers wereharvested and serum was collected. |
Dosage form |
40mg/kg; i.p.; two times |
Applications |
Farrerol pretreatment alleviated acute liver failure and maintained the survival rate of mice via activation of both Nrf2-mediated antioxidative cascades and mitochondrial autophagy. |
References: |
Cas No. | 24211-30-1 | SDF | |
别名 | 杜鹃素 | ||
Canonical SMILES | O=C1C[C@@H](C2=CC=C(O)C=C2)OC3=C(C)C(O)=C(C)C(O)=C13 | ||
分子式 | C17H16O5 | 分子量 | 300.31 |
溶解度 | DMSO: 250 mg/mL (832.47 mM) | 储存条件 | 4°C, protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 3.3299 mL | 16.6495 mL | 33.2989 mL |
5 mM | 0.666 mL | 3.3299 mL | 6.6598 mL |
10 mM | 0.333 mL | 1.6649 mL | 3.3299 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet